Research any topic before you write.
Find related topics. | Discover entities. | See connections. | Build a topical map.
Zoledronic acid, also known as zoledronate and sold under the brand name Zometa among others, by Novartis among others, is a medication used to treat a number of bone diseases. These include osteoporosis, high blood calcium due to cancer, bone breakdown due to cancer, Paget's disease of bone and Duchenne muscular dystrophy (DMD). It is given by injection…
Applications, Research & Art
Explore the main themes, entities and connections around Zoledronic acid. Start with the topic map, then use the sections below for research and deeper semantic analysis.
Start with a few of the strongest sections from the source topic. These are research directions, not a list of keywords you must use.
High-confidence facts extracted from structured source data. Use them as anchors for further research.
Browse the full topic structure. Each item opens a new analysis centered on that subject.
Deeper signals for content research, entity SEO and topical coverage. The plain-language headings explain what each technical view is useful for.
See the strongest relationship patterns around the current topic before diving into the raw triples.
Use these terms to understand the vocabulary surrounding the topic, not as a checklist for keyword stuffing.
acid zoledronic bone cancer osteoporosis fractures effects may treatment patients also cells use include kidney side bisphosphonate used disease medicines
| Subject | Predicate | Object | Confidence | Src |
|---|---|---|---|---|
| Zoledronic acid | 3D model (JSmol) | Interactive image | 1.00 | infobox |
| Zoledronic acid | AHFS/Drugs.com | Monograph | 1.00 | infobox |
| Zoledronic acid | ATC code | M05BA08 (WHO) | 1.00 | infobox |
| Zoledronic acid | CAS Number | 118072-93-8 | 1.00 | infobox |
| Zoledronic acid | ChEBI | CHEBI:46557 | 1.00 | infobox |
| Zoledronic acid | ChEMBL | ChEMBL924 Y | 1.00 | infobox |
| Zoledronic acid | ChemSpider | 61986 | 1.00 | infobox |
| Zoledronic acid | CompTox Dashboard (EPA) | DTXSID0042668 | 1.00 | infobox |
| Zoledronic acid | Drug class | Bisphosphonate | 1.00 | infobox |
| Zoledronic acid | DrugBank | DB00399 | 1.00 | infobox |
| Zoledronic acid | Elimination half-life | 146 hours | 1.00 | infobox |
| Zoledronic acid | Excretion | Kidney (partial) | 1.00 | infobox |
| Zoledronic acid | Formula | C5H10N2O7P2 | 1.00 | infobox |
| Zoledronic acid | IUPHAR/BPS | 3177 | 1.00 | infobox |
| Zoledronic acid | KEGG | D08689 N | 1.00 | infobox |
| Zoledronic acid | KEGG | D01968 N | 1.00 | infobox |
| Zoledronic acid | Legal status | AU: S4 (Prescription only) | 1.00 | infobox |
| Zoledronic acid | Legal status | US: ℞-only | 1.00 | infobox |
| Zoledronic acid | Legal status | EU: Rx-only | 1.00 | infobox |
| Zoledronic acid | License data | US DailyMed: Zoledronic acid | 1.00 | infobox |
| Zoledronic acid | MedlinePlus | a605023 | 1.00 | infobox |
| Zoledronic acid | Metabolism | Nil | 1.00 | infobox |
| Zoledronic acid | Molar mass | 272.090 g·mol−1 | 1.00 | infobox |
| Zoledronic acid | Other names | zoledronate | 1.00 | infobox |
| Zoledronic acid | PDB ligand | ZOL (PDBe, RCSB PDB) | 1.00 | infobox |
| Zoledronic acid | Pregnancy category | AU: B3 | 1.00 | infobox |
| Zoledronic acid | Protein binding | 22% | 1.00 | infobox |
| Zoledronic acid | PubChem CID | 68740 | 1.00 | infobox |
| Zoledronic acid | Routes of administration | Intravenous | 1.00 | infobox |
| Zoledronic acid | Trade names | Reclast, Zometa, others | 1.00 | infobox |
These clusters group vocabulary that occurs around closely connected concepts in the source material.
Bridges can reveal useful research angles that are easy to miss in a flat list of related terms.